Human papillomavirus vaccination and genital warts in young indigenous Australians: National sentinel surveillance data

Medical Journal of Australia

Volumn 206, Issue 5, 2017, Pages 204-209

  Ali, Hammad ^a   McManus, Hamish ^a   O’Connor, Catherine C ^b   Callander, Denton ^a   Kong, Marlene ^a   Graham, Simon ^c   Saulo, Dina ^a   Fairley, Christopher K ^d   Regan, David G ^a   Grulich, Andrew ^a   Low, Nicola ^e   Guy, Rebecca J ^a   Donovan, Basil ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ALFRED HOSPITAL   (Australia)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONDYLOMA ACUMINATUM; FEMALE; HUMAN; INDIGENOUS AUSTRALIAN; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; PAPILLOMAVIRUS INFECTION; SENSITIVITY ANALYSIS; SENTINEL SURVEILLANCE; SEXUAL HEALTH; VACCINATION; AGE DISTRIBUTION; AUSTRALIA; CONDYLOMATA ACUMINATA; EVALUATION STUDY; OCEANIC ANCESTRY GROUP; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVENTIVE HEALTH SERVICE; PROGRAM EVALUATION; SEX RATIO; STATISTICS AND NUMERICAL DATA; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AUSTRALIA; CHILD; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; MALE; OCEANIC ANCESTRY GROUP; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROGRAM EVALUATION; SENTINEL SURVEILLANCE; SEX DISTRIBUTION; YOUNG ADULT;

EID: 85016191932     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja16.00597     Document Type: Article

References (25)

1. Garland SM, Skinner SR, Brotherton JML. Adolescent and young adult HPV vaccination in Australia: achievements and challenges. Prev Med 2011; 53: S29-S35.
2. Forster AS, Marlow LAV, Wardle J, et al. Interest in having HPV vaccination among adolescent boys in England. Vaccine 2012; 30: 4505-4510.
3. Olsson SE, Villa LL, Costa RLR, et al. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18. L1 virus-like particle (VLP) vaccine. Vaccine 2007; 25: 4931-4939.
4. Gertig DM, Brotherton JML, Saville M. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health 2011; 8: 171-178.
5. Ali H, Donovan B, Wand H, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 2013; 346: f2032.
6. Read TRH, Hocking JS, Chen MY, et al. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 2011; 87: 544-547.
7. Ali H, Guy RJ, Wand H, et al. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infect Dis 2013; 13: 1-6.
8. Smith MA, Liu B, McIntyre P, et al. Fall in genital warts diagnoses in the general and Indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data. J Infect Dis 2014; 211: 91-99.
9. Tabrizi SN, Brotherton JM, Kaldor JM, et al. Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis 2012; 206: 1645-1651.
10. Chow EP, Danielewski JA, Fehler G, et al. Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study. Lancet Infect Dis 2015; 15: 1314-1323.
11. Brotherton JML, Fridman M, May CL, et al. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011; 377: 2085-2092.
12. Whop LJ, Baade P, Garvey G, et al. Cervical abnormalities are more common among Indigenous than other Australian women: a retrospective record-linkage study, 2000e2011. PLoS One 2016; 11: 1-12.
13. Vasilevska M, Ross SA, Gesink D, et al. Relative risk of cervical cancer in indigenous women in Australia, Canada, New Zealand, and the United States: a systematic review and meta-analysis. J Pub Health Pol 2012; 33: 148-164.
14. Australian Institute of Health and Welfare. The health and welfare of Australia’s Aboriginal and Torres Strait Islander peoples (AIHW Cat. No. IHW 42). Canberra: AIHW, 2011.
15. O’Connor C, Ali H, Guy R, et al. High chlamydia positivity rates In Indigenous people attending Australian sexual health services. Med J Aust 2014; 200: 595-598. https://www.mja.com.au/journal/2014/200/10/high-chlamydia-positivityrates-indigenous-people-attending-australian-sexual
16. The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2015. Sydney: The Kirby Institute, UNSW Australia, 2015. http://kirby.unsw.edu.au/sites/default/files/hiv/resources/2015%20Annual%20Surveillance% 20Report%20of%20HIV%2C%20viral%20hepatitis%2C%20STIs.pdf (accessed Jan 2017).
17. The Kirby Institute. Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people: annual surveillance report 2015. Sydney: The Kirby Institute, UNSW Australia, 2015. http://kirby.unsw.edu.au/sites/default/files/hiv/resources/2015%20Aboriginal%20Surveillance%20Report%20of% 20HIV%2C%20viral%20hepatitis%2C%20STIs.pdf (accessed Jan 2017).
18. Australian Government, Department of the Prime Minister and Cabinet. Closing the Gap. Prime Minister’s report 2016. Canberra: Department of the Prime Minister and Cabinet, 2016. http://closingthegap.dpmc.gov.au/assets/pdfs/ closing_the_gap_report_2016.pdf (accessed Jan 2017).
19. Australian Government, Department of Health. Fourth National Aboriginal and Torres Strait Islander bloodborne viruses and sexually transmissible infections strategy, 2014e2017. Canberra: Department of Health, 2014. https://health.gov.au/internet/main/publishing.nsf/Content/4CBA8EFCE045DFA9CA257BF0002 0A9D0/$File/ATSI-BBV-STI-Strategy2014-v3.pdf (accessed Jan 2017).
20. Drolet M, Bénard É, Boily M-C, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2015; 15: 565-580.
21. Ali H, Guy RJ, Fairley CK, et al. Understanding trends in genital Chlamydia trachomatis can benefit from enhanced surveillance: findings from Australia. Sex Transm Infect 2012; 88: 552-557.
22. Brotherton J, Murray SL, Hall MA, et al. Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. Med J Aust 2013; 199: 614-617. https://www.mja.com.au/journal/2013/199/9/human-papillomavirus-vaccinecoverage-among-female-australian-adolescentssuccess
23. Ali H, Donovan B, Fairley CK, et al. Increasing access by priority populations to Australian sexual health clinics. Sex Transm Dis 2013; 40: 819-821.
24. Ali H, Donovan B, Fairley CK, et al. Are Australian sexual health clinics attracting priority populations? Sex Health 2013; 10: 456-459.
25. Ward J, Bryant J, Worth H, et al. Use of health services for sexually transmitted and blood-borne viral infections by young Aboriginal people in New South Wales. Aust J Prim Health 2013; 19: 81-86